Journal article
Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors
SS Dominy, C Lynch, F Ermini, M Benedyk, A Marczyk, A Konradi, M Nguyen, U Haditsch, D Raha, C Griffin, LJ Holsinger, S Arastu-Kapur, S Kaba, A Lee, MI Ryder, B Potempa, P Mydel, A Hellvard, K Adamowicz, H Hasturk Show all
Science Advances | AMER ASSOC ADVANCEMENT SCIENCE | Published : 2019
Open access
Abstract
Porphyromonas gingivalis, the keystone pathogen in chronic periodontitis, was identified in the brain of Alzheimer’s disease patients. Toxic proteases from the bacterium called gingipains were also identified in the brain of Alzheimer’s patients, and levels correlated with tau and ubiquitin pathology. Oral P. gingivalis infection in mice resulted in brain colonization and increased production of A 1–42 , a component of amyloid plaques. Further, gingipains were neurotoxic in vivo and in vitro, exerting detrimental effects on tau, a protein needed for normal neuronal function. To block this neurotoxicity, we designed and synthesized small-molecule inhibitors targeting gingipains. Gingipain inh..
View full abstractGrants
Awarded by National Institute of Dental and Craniofacial Research
Funding Acknowledgements
P.M. was supported by National Science Center 2016/23/B/NZ5/011469, Poland. J.P. was supported by NIH/NIDCR grant R01DE022597. This work was funded by Cortexyme Inc.